Literature DB >> 31519123

CD8+ T-cells of CLL-bearing mice acquire a transcriptional program of T-cell activation and exhaustion.

Laura Llaó Cid1,2, Bola S Hanna1, Murat Iskar1, Philipp M Roessner1, Selcen Öztürk1, Peter Lichter1, Marc Zapatka1, Martina Seiffert1.   

Abstract

Chronic lymphocytic leukemia (CLL) is associated with an accumulation of oligoclonal CD8+ effector T-cells, which control leukemia progression in mice, but gradually acquire a dysfunctional phenotype along with disease progression. Exhaustion of CD8+ T-cells is characterized by increased expression of inhibitory receptors like PD-1, decreased proliferation, and reduced effector function such as cytokine production, which reduces anti-tumor control. Despite the accumulation of exhausted PD-1+ CD8+ T-cells in secondary lymphoid organs of CLL patients, immune checkpoint blockade as a means to reinvigorate anti-tumor T-cell activity has not shown the expected efficacy. This highlights the need for a better understanding of T-cell exhaustion in CLL. Here, we uncover the transcriptional program of T-cell exhaustion in CLL by comparing naïve with dysfunctional effector CD8+ T-cells with high PD-1 expression from mice after adoptive transfer of Eµ-TCL1 leukemic cells. Our data provide clear evidence for activation-induced dysfunction of CD8+ T-cells in the CLL microenvironment and assess the heterogeneity in the expression of functionally relevant proteins in specific clusters of CD8+ T-cells at a single-cell level.

Entities:  

Keywords:  CD8+ T-cells; CLL; T-cell exhaustion; single-cell analyses

Mesh:

Year:  2019        PMID: 31519123     DOI: 10.1080/10428194.2019.1660972

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  9 in total

1.  Chronic lymphocytic leukemia: from molecular pathogenesis to novel therapeutic strategies.

Authors:  Julio Delgado; Ferran Nadeu; Dolors Colomer; Elias Campo
Journal:  Haematologica       Date:  2020-07-02       Impact factor: 9.941

Review 2.  T Cells in Chronic Lymphocytic Leukemia: A Two-Edged Sword.

Authors:  Elisavet Vlachonikola; Kostas Stamatopoulos; Anastasia Chatzidimitriou
Journal:  Front Immunol       Date:  2021-01-20       Impact factor: 7.561

3.  HDAC6 Inhibition Alleviates CLL-Induced T-Cell Dysfunction and Enhances Immune Checkpoint Blockade Efficacy in the Eμ-TCL1 Model.

Authors:  Kamira Maharaj; John J Powers; Melanie Mediavilla-Varela; Alex Achille; Wael Gamal; Steven Quayle; Simon S Jones; Eva Sahakian; Javier Pinilla-Ibarz
Journal:  Front Immunol       Date:  2020-11-23       Impact factor: 7.561

4.  EOMES and IL-10 regulate antitumor activity of T regulatory type 1 CD4+ T cells in chronic lymphocytic leukemia.

Authors:  Philipp M Roessner; Laura Llaó Cid; Ekaterina Lupar; Ana Izcue; Martina Seiffert; Tobias Roider; Marie Bordas; Christoph Schifflers; Lavinia Arseni; Ann-Christin Gaupel; Fabian Kilpert; Marit Krötschel; Sebastian J Arnold; Leopold Sellner; Dolors Colomer; Stephan Stilgenbauer; Sascha Dietrich; Peter Lichter
Journal:  Leukemia       Date:  2021-02-01       Impact factor: 11.528

Review 5.  T-cells in chronic lymphocytic leukemia: Guardians or drivers of disease?

Authors:  Philipp M Roessner; Martina Seiffert
Journal:  Leukemia       Date:  2020-05-26       Impact factor: 11.528

6.  A Specific CD44lo CD25lo Subpopulation of Regulatory T Cells Inhibits Anti-Leukemic Immune Response and Promotes the Progression in a Mouse Model of Chronic Lymphocytic Leukemia.

Authors:  Agnieszka Goral; Malgorzata Firczuk; Klaudyna Fidyt; Marta Sledz; Francesca Simoncello; Karolina Siudakowska; Giulia Pagano; Etienne Moussay; Jérôme Paggetti; Patrycja Nowakowska; Stefania Gobessi; Joanna Barankiewicz; Aleksander Salomon-Perzynski; Federica Benvenuti; Dimitar G Efremov; Przemyslaw Juszczynski; Ewa Lech-Maranda; Angelika Muchowicz
Journal:  Front Immunol       Date:  2022-02-28       Impact factor: 7.561

Review 7.  Chronic lymphocytic leukemia: from molecular pathogenesis to novel therapeutic strategies.

Authors:  Julio Delgado; Ferran Nadeu; Dolors Colomer; Elias Campo
Journal:  Haematologica       Date:  2020-09-01       Impact factor: 9.941

8.  Expression Analysis of Fyn and Bat3 Signal Transduction Molecules in Patients with Chronic Lymphocytic Leukemia.

Authors:  Fereshteh Hosseini-Valiki; Saeid Taghiloo; Golvash Tavakolian; Omolbanin Amjadi; Mohsen Tehrani; Akbar Hedayatizadeh-Omran; Reza Alizadeh-Navaei; Ehsan Zaboli; Ramin Shekarriz; Hossein Asgarian-Omran
Journal:  Asian Pac J Cancer Prev       Date:  2020-09-01

9.  Myeloid-derived suppressor cell subtypes differentially influence T-cell function, T-helper subset differentiation, and clinical course in CLL.

Authors:  Gerardo Ferrer; Byeongho Jung; Pui Yan Chiu; Rukhsana Aslam; Florencia Palacios; Andrea Nicola Mazzarello; Stefano Vergani; Davide Bagnara; Shih-Shih Chen; Sophia Yancopoulos; Aliki Xochelli; Xiao-Jie Yan; Jan A Burger; Jacqueline C Barrientos; Jonathan E Kolitz; Steven L Allen; Kostas Stamatopoulos; Kanti R Rai; Barbara Sherry; Nicholas Chiorazzi
Journal:  Leukemia       Date:  2021-05-02       Impact factor: 12.883

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.